Skip to content

Evolent Health, Inc. EVH Reportable segment — Revenue

Similar metrics at other companies

Omada Health, Inc. Common Stock logo
OMDAReportable Segment — Revenue
$78.05M+42.0%
LegalZoom.com, Inc. logo
LZReportable Segment — Revenue
$206.78M+12.9%
Claritev Corporation logo
CTEVReportable Segment — Revenue
$244.68M+5.8%
Concentrix Corporation logo
CNXCReportable Segment — Revenue
$2.5B+5.4%
Concentra Group Holdings Parent logo
CONReportable Segment — Revenue
$569.56M+13.7%
Weave Communications logo
WEAVReportable Segment — Revenue
$65.5M+17.4%

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s reportable segment — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s reportable segment — revenue?
Evolent Health, Inc. (EVH) reported reportable segment — revenue of $496.25M in Q1 2026.
How has Evolent Health, Inc.'s reportable segment — revenue changed year-over-year?
Evolent Health, Inc.'s reportable segment — revenue increased by 2.6% year-over-year, from $483.65M to $496.25M.
What is the long-term trend for Evolent Health, Inc.'s reportable segment — revenue?
Over 3 years (2022 to 2025), Evolent Health, Inc.'s reportable segment — revenue has grown at a 11.5% compound annual growth rate (CAGR), from $1.35B to $1.88B.
What does reportable segment — revenue mean?
This represents the total gross income generated by the primary business segment through its healthcare delivery and payment services. It serves as a key indicator of the segment's market reach and the scale of its value-based care operations.